Discovery and Innovation in Cancer Immunology: Revolutionizing Treatment through Immunotherapy

February 28-March 3, 2027
JW Marriott Los Angeles L.A. Live
Los Angeles, California

Cochairs

Nina Bhardwaj, Icahn School of Medicine at Mount Sinai, New York, New York
Elizabeth M. Jaffee, Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland
Antoni Ribas, UCLA Jonsson Comprehensive Cancer Center, Los Angeles, California

Building on the success of the 2025 and 2026 AACR IO conferences, AACR invites you to join us again in Los Angeles for AACR IO 2027.  The third conference in this series will once again encompass the very best of basic, translational, and clinical research in immunology, inflammation, and immunotherapies for cancer, including immuno-oncology (IO) drugs, inflammatory modulators, vaccines, and cellular therapies. This conference has attracted over 600 basic scientists, translational researchers, clinical investigators, regulators, industry, investors, and the lay press – and we anticipate a larger audience in 2027. The program will once again include a mix of keynote lectures, major symposia, spotlight sessions, educational sessions, and poster sessions with exhibits will cover the spectrum of the IO field – including late-breaking clinical trials sessions highlighting new agents and novel IO combinations, and the results of practice-changing clinical trials. Make plans to join AACR today for this unique opportunity to network with immuno-oncology thought-leaders from around the world.

Scientific Committee Members

Rafi Ahmed, Emory University, Atlanta, Georgia
Lieping Chen, Yale University, New Haven, Connecticut
Yvonne Y. Chen, University of California, Los Angeles, California
Luca Gattinoni, Leibniz Institute for Immunotherapy, Regensburg, Germany
Philip D. Greenberg, Fred Hutchinson Cancer Center, Seattle, Washington
Alena Gros, VHIO Vall D’Hebron Institute of Oncology, Barcelona, Spain
Carl H. June, Perelman School of Medicine University of Pennsylvania, Philadelphia, Pennsylvania
Anusha Kalbasi, Stanford University, Stanford, California
Lewis L. Lanier, University of California, San Francisco, California
Sherene Loi, Peter MacCallum Cancer Centre, Melbourne, Australia
Georgina V. Long, University of Sydney, Sydney, Australia (may not be able to attend)
Alexander Marson, University of California, San Francisco, California
Ignacio Melero, Clínica Universidad de Navarra, Pamplona, Spain
Ira Mellman, Parker Institute for Cancer Immunotherapy, San Francisco, California
Cristina Puig Sais, University of California, Los Angeles, California
Gabriel A. Rabinovich, Instituto de Biología y Medicina Experimental, Buenos Aires, Argentina
Yardena Samuels, Weizmann Institute of Science, Rehovot, Israel
Ton N. Schumacher, Netherlands Cancer Institute, Amsterdam, Netherlands
Daniel Shao-Weng Tan, National Cancer Centre Singapore, Singapore
Marcel R.M. van den Brink, City of Hope National Medical Center, Duarte, California
Robert Vonderheide, Penn Medicine Abramson Cancer Center, Philadelphia, Pennsylvania
E. John Wherry, University of Pennsylvania, Philadelphia, Pennsylvania

Clinical Trial and Late-Breaking Abstracts Committee

Renier J. Brentjens, Roswell Park Comprehensive Cancer Center, Roswell Park, New York
Tina Cascone, The University of Texas MD Anderson Cancer Center, Houston, Texas
Ameya S. Champhekar, University of California, Los Angeles, California
Jason A. Chesney, University of Louisville, Louisville, Kentucky
Stephanie K. Dougan, Dana-Farber Cancer Institute, Boston, Massachusetts
John B.A.G. Haanen, Netherlands Cancer Institute, Amsterdam, Netherlands
Patrick Hwu, Moffitt Cancer Center, Tampa, Florida
Gordon J. Freeman, Dana-Farber Cancer Institute, Boston, Massachusetts
Quyhn-Thu Le, Stanford Cancer Institute, Stanford, California
Ignacio Melero, Clínica Universidad de Navarra, Pamplona, Spain
Theodore Nowicki, University of California, Los Angeles, California
Robert Prins, University of California, Los Angeles, California
Katayoun Rezvani, The University of Texas MD Anderson Cancer Center, Houston, Texas
Pedro J. Romero, Novigenix SA and University of Lausanne, Lausanne, Switzerland
Lili Yang, University of California, Los Angeles, California

Please Note: All presentations at this event represent the opinions of the presenter and do not represent the position or the opinion of the AACR or its members.

Conference Hashtag

Join the social media conversation around this AACR conference by using the official hashtag:
#AACRIO27